Filing Details
- Accession Number:
- 0001415889-21-003266
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 19:13:11
- Reporting Period:
- 2021-06-25
- Accepted Time:
- 2021-06-29 19:13:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646649 | Jonathan Sheena | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-25 | 87 | $5.40 | 455,472 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-25 | 87 | $121.63 | 455,385 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-25 | 52 | $9.59 | 455,437 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-25 | 52 | $121.63 | 455,385 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-25 | 700 | $10.41 | 456,085 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-25 | 700 | $121.58 | 455,385 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-25 | 700 | $9.29 | 456,085 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-25 | 700 | $121.59 | 455,385 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-06-27 | 446 | $0.00 | 455,831 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-28 | 201 | $117.57 | 455,630 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-25 | 87 | $0.00 | 87 | $5.40 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-25 | 52 | $0.00 | 52 | $9.59 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-25 | 700 | $0.00 | 700 | $10.41 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-25 | 700 | $0.00 | 700 | $9.29 |
| Common Stock | Restricted Stock Unit | Disposition | 2021-06-27 | 446 | $0.00 | 446 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,958 | 2026-04-07 | No | 4 | M | Direct | |
| 40,778 | 2026-04-07 | No | 4 | M | Direct | |
| 38,368 | 2027-06-08 | No | 4 | M | Direct | |
| 21,453 | 2028-03-08 | No | 4 | M | Direct | |
| 4,917 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.02 to $121.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.04 to $121.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.10 to $121.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.11 to $121.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 27, 2021.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
- The option shares vested fully and became exercisable on November 20, 2019.
- The option shares vested fully and became exercisable on April 1, 2020.
- The option shares vested fully and became exercisable on March 21, 2021.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vested on March 27, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
